TY  - GEN
AU  - Sobrino-García, Miriam
AU  - Moreno, Esther M.
AU  - Muñoz-Bellido, Francisco J.
AU  - Gracia-Bara, Maria T.
AU  - Laffond, Elena
AU  - Doña, Inmaculada
AU  - Martín, Cristina
AU  - Macías, Eva M.
AU  - de Arriba, Sonia
AU  - Campanón, Valle
AU  - Gallardo, Alicia
AU  - Dávila, Ignacio
PY  - 2020
DO  - 10.3389/fphar.2020.584633
UR  - http://hdl.handle.net/20.500.12105/18164
AB  - Introduction: Being labelled as allergic to different drugs results in patients receiving other treatments, which are more toxic, less effective and more expensive. We aimed to analyze different studies of the costs of drug hypersensitivity...
LA  - eng
PB  - Frontiers Media
KW  - Beta-lactam
KW  - Cost
KW  - Delabelling
KW  - Drug hypersensitivity
KW  - Non-steroidal anti-inflammatory drug
KW  - Penicillin
KW  - Drug allergy
KW  - Beta-lactamas
KW  - Costos y análisis de costo
KW  - Hipersensibilidad a las drogas
KW  - Antiinflamatorios no esteroideos
KW  - Penicilinas
KW  - beta-Lactams
KW  - Humans
KW  - Drug Hypersensitivity
KW  - Retrospective Studies
KW  - Penicillins
KW  - Adult
KW  - Child
TI  - Analysis of the Costs Associated With the Elective Evaluation of Patients Labelled as Allergic to Beta-Lactams or Nonsteroidal Antiinflamatory Agents
TY  - review article
ER  -